US EditionResearch Analysts Set Expectations for Veracyte Q2 Earnings
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Research Analysts Set Expectations for Veracyte Q2 Earnings
Veracyte, Inc. (NASDAQ:VCYT – Free Report) – Stock analysts at William Blair raised their Q2 2025 EPS estimates for shares of Veracyte in a report issued on Tuesday, May 13th. William Blair analyst A. Brackmann now forecasts that the biotechnology company will earn $0.19 per share for the quarter, up from their previous estimate of […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
